Results 191 to 200 of about 600,739 (294)

​Did a Non‐Medical Biosimilar Switching Policy Cause an Increase in Non‐Biologic/Biosimilar Health Care Resource Utilization or Cost in Patients With Inflammatory Arthritis?

open access: yesArthritis Care &Research, EarlyView.
Objective This study aimed to evaluate the impact of a series of policies that mandated switching patients with inflammatory arthritis (IA) from an originator biologic to a biosimilar in British Columbia, Canada, on health care resource use and cost.
HaoHung Dang   +4 more
wiley   +1 more source

Performance Government: A Roundtable Discussion

open access: yesMaine Policy Review, 1999
Roundtable
doaj  

DeepSeek for healthcare: do no harm? [PDF]

open access: yesAI Ethics
Anibal J   +8 more
europepmc   +1 more source

Reduction in Renal Relapse and Preservation of Long‐Term Kidney Function After Lupus Low Disease Activity in Patients With Lupus Nephritis

open access: yesArthritis Care &Research, EarlyView.
Objective Lupus low disease activity state (LLDAS) is a validated treatment target in systemic lupus erythematosus (SLE), but limited studies have explored the role of LLDAS in lupus nephritis (LN). This study aims to investigate the frequency and predictors of LLDAS attainment and its benefit on LN relapse and renal function preservation in patients ...
Chak Kwan Cheung   +6 more
wiley   +1 more source

Rethinking Government in Maine

open access: yesMaine Policy Review, 1995
Steve Ballard
doaj  

The resolution of Advisory council «How to improve treatment results functional dyspepsia and irritable bowel syndrome»?

open access: yesРоссийский журнал гастроэнтерологии, гепатологии, колопроктологии, 2016
V. T. Ivashkin   +17 more
doaj   +1 more source

Lived and Care Experiences of Chronic Musculoskeletal Shoulder Pain in Australian Adults: A Qualitative Study

open access: yesArthritis Care &Research, EarlyView.
Objective Australian evidence on lived and care experiences of chronic musculoskeletal shoulder pain (CMSP), irrespective of disorder classification or disease, is limited. However, such evidence is important for person‐centered care and informing local service pathways and care guidelines or standards.
Sonia Ranelli   +8 more
wiley   +1 more source

Recurrent cholestasis in 16 year-old patient (clinical case presentation)

open access: yesРоссийский журнал гастроэнтерологии, гепатологии, колопроктологии, 2018
I. N. Tikhonov   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy